Evaluating functional outcomes in diabetic vitreous hemorrhage: Comparative analysis of diabetes type and adjunctive preoperative factors
Authors:
- 3 August 2026
- journal article
- Published by Wolters Kluwer Health in Saudi Journal of Ophthalmology
Abstract
PURPOSE: The purpose of this study was to evaluate visual outcomes following pars plana vitrectomy (PPV) in diabetic patients with vitreous hemorrhage (VH), comparing type 1 and type 2 diabetes mellitus, and to assess the influence of preoperative intravitreal bevacizumab (IVB) on postoperative visual recovery. METHODS: This retrospective study included 204 eyes from diabetic patients who underwent PPV for nonclearing VH between January 2021 and March 2025. Patients were categorized by diabetes type and stratified according to preoperative IVB administration. Best-corrected visual acuity (BCVA) was recorded preoperatively and at 1 st and 3 rd postoperative months. Visual acuity values were converted to the logarithm of the minimum angle of resolution for analysis. Statistical tests included paired and independent t -tests, Wilcoxon signed-rank test, Mann–Whitney U test, and Chi-square test, with P < 0.05 considered statistically significant. RESULTS: Significant postoperative BCVA improvement was observed in both diabetic subgroups ( P < 0.001). Type 2 diabetic eyes exhibited greater median visual gain overall. In type 1 diabetic patients, those receiving preoperative IVB showed more pronounced visual improvement at 3 months compared to untreated counterparts, although intergroup differences did not reach statistical significance. In type 2 diabetics, the additional benefit of IVB was limited. No major intraoperative complications or cases of endophthalmitis occurred. CONCLUSION: PPV is effective in restoring vision in both type 1 and type 2 diabetic VH. Type 2 diabetics tend to achieve more consistent visual gains, while type 1 diabetics may benefit more substantially from adjunctive preoperative IVB. These findings support individualized perioperative planning in diabetic VH management.Keywords
This publication has 18 references indexed in Scilit:
- Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic RetinopathyOphthalmology Retina, 2024
- Infographic: Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results from the Diabetic Retinopathy Vitrectomy StudyEye, 2023
- Anti-VEGF crunch syndrome in proliferative diabetic retinopathy: A reviewSurvey of Ophthalmology, 2021
- Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic RetinopathyJAMA, 2020
- Preoperative Bevacizumab for Tractional Retinal Detachment in Proliferative Diabetic Retinopathy: A Prospective Randomized Clinical TrialAmerican Journal of Ophthalmology, 2019
- Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trialsBritish Journal of Ophthalmology, 2017
- The Effect of Adjunctive Intravitreal Bevacizumab for Preventing Postvitrectomy Hemorrhage in Proliferative Diabetic RetinopathyOphthalmology, 2011
- Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathyGraefe's Archive for Clinical and Experimental Ophthalmology, 2010
- Microincision Vitrectomy Surgery and Intravitreal Bevacizumab as a Surgical Adjunct to Treat Diabetic Traction Retinal DetachmentOphthalmology, 2009
- Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathyBritish Journal of Ophthalmology, 2007